Neurocrine: brands it owns and its ownership tree
Neurocrine (NASDAQ: NBIX) is a publicly listed company headquartered in San Diego, United States that owns 2 consumer brands.[1]
Neurocrine is a US neuroscience company. Its 2025 Form 10-K reports sales of Ingrezza and Crenessity.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
subsidiaries recorded
Company facts
- Legal name
- Neurocrine Biosciences, Inc.
- Headquarters
- 🇺🇸 San Diego, United States
- Type
- publicly listed company · all publicly listed company owners
- Founded
- 1992
- Tickers
- NASDAQ: NBIX
- Identifiers
- SEC CIK 0000914475
- Last verified
- · 1 sources
Brands Neurocrine owns
2 brands in 1 category.
Drug makers (2)
- Crenessity
Biotechnology · 🇺🇸 United States
- Ingrezza
Biotechnology · 🇺🇸 United States
Full list of 2 brands with sources · Interactive ownership tree
Ownership structure
No company is recorded as controlling Neurocrine.
Financials and filings
Neurocrine financial history
Headline figures from Neurocrine's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2020–2025. Revenue moved from $1.05bn to $2.86bn, an average of 22.3% a year (calculated).
| Fiscal year ended | Revenue | Operating income | Operating margin | Net income | Total assets | Long-term debt | Filing |
|---|---|---|---|---|---|---|---|
| $2.86bn | $619.1m | 21.6% | $478.6m | $4.63bn | — | 10-K | |
| $2.36bn | $570.5m | 24.2% | $341.3m | $3.72bn | — | 10-K | |
| $1.89bn | $250.9m | 13.3% | $249.7m | $3.25bn | — | 10-K | |
| $1.49bn | $249m | 16.7% | $154.5m | $2.37bn | — | 10-K | |
| $1.13bn | $102.5m | 9.0% | $89.6m | $2.07bn | — | 10-K | |
| $1.05bn | $163m | 15.6% | $407.3m | $1.73bn | — | 10-K |
Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.
Neurocrine SEC filings
The documents behind the figures on this page, as listed in the SEC's EDGAR index. Each links to the filing itself.
Annual reports
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
- Annual report, filed (10-K)
Proxy statements
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
Recent current and quarterly reports
| Filed | Form | What it declares |
|---|---|---|
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Departure or appointment of directors or officers | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Departure or appointment of directors or officers; Results of a shareholder vote | |
| 8-K | Entry into a material agreement; Completion of an acquisition or disposal of assets; Creation of a direct financial obligation; Regulation FD disclosure | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Entry into a material agreement | |
| 8-K | Results of operations and financial condition | |
| 8-K | Departure or appointment of directors or officers | |
| 8-K | Results of operations and financial condition |
Neurocrine in the global legal-entity registry
The Global Legal Entity Identifier Foundation (GLEIF) keeps an open register of legal entities. Each entity reports its own parents. We show it as a cross-check on the ownership recorded on this page, which is built from filings.
- Legal entity identifier (LEI)
- 549300FECER0XBN49756
- Registered name
- Neurocrine Biosciences, Inc. (US)
- Registration status
- Lapsed · record updated 29 July 2026
- Parent
- None named: its parent has not been disclosed publicly.
- Retrieved
- · GLEIF record (JSON)
Frequently asked questions
What brands does Neurocrine own?
Neurocrine owns 2 consumer brands tracked here, including Crenessity and Ingrezza.
Is Neurocrine an American company?
Yes. Neurocrine is headquartered in San Diego, United States and was founded in 1992.
Who owns Neurocrine?
Neurocrine is a publicly listed company owned by its shareholders; it trades as NBIX on the NASDAQ.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Neurocrine Biosciences, Inc. Annual Report on Form 10-K filed 2026-02-11 — SEC EDGAR, SEC Form 10-K, published 11 February 2026; retrieved 8 November 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.